Fennec Pharmaceuticals (FENC) Net Income towards Common Stockholders (QoQ) (2010 - 2025)
Fennec Pharmaceuticals (FENC) Net Income towards Common Stockholders (QoQ) (2010 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Fennec Pharmaceuticals | 292.91 Mn | 256.13 Mn | 12.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -656.66% |
| Sep 30, 2025 | 80.25% |
| Jun 30, 2025 | -171.05% |
| Mar 31, 2025 | 22.45% |
| Dec 31, 2024 | 73.72% |
| Sep 30, 2024 | -3.59% |
| Jun 30, 2024 | -142.72% |
| Mar 31, 2024 | 592.97% |
| Dec 31, 2023 | -47.83% |
| Sep 30, 2023 | 67.06% |
| Jun 30, 2023 | 9.78% |
| Mar 31, 2023 | 11.40% |
| Dec 31, 2022 | 16.45% |
| Sep 30, 2022 | -59.19% |
| Jun 30, 2022 | -40.67% |
| Mar 31, 2022 | 15.53% |
| Dec 31, 2021 | -0.97% |
| Sep 30, 2021 | -6.36% |
| Jun 30, 2021 | 19.30% |
| Mar 31, 2021 | 85.76% |